Tabbara Marina M, González Javier, Ciancio Gaetano
Department of Surgery, University of Miami Miller School of Medicine; Miami, Florida.
Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital; Miami, Florida.
Med Res Arch. 2022 Jul;10(7). doi: 10.18103/mra.v10i7.2913. Epub 2022 Jul 31.
Renal cell carcinoma (RCC) accounts for 2-3% of all malignant disease in adults and has a propensity to infiltrate the surrounding adjacent structures with a biologic predisposition for vascular invasion. This tropism for the venous system facilitates propagation into the renal vein and inferior vena cava (IVC) in up to 25% of patients with RCC. Surgical resection remains the mainstay treatment for RCC with venous tumor thrombus (TT) extension and the only hope for a potential cure. Higher thrombus levels correlate with more advanced stages of disease and thus poorer survival rates. Although CPB with circulatory arrest has been successfully performed during resection of these tumors, its use remains controversial due to the risk of coagulopathy, platelet dysfunction, and central nervous system complications. Complete intraabdominal surgical excision of level III thrombi can be achieved without sternotomy and CPB by utilizing hepatic mobilization maneuvers. The purpose of this review is to provide an update on the surgical management of these difficult cases of RCC with supradiaphragmatic tumor thrombi, including a description of transplant-based techniques that avoid sternotomy and cardiopulmonary bypass (CPB), minimizing intra- and post-operative complications.
肾细胞癌(RCC)占成人所有恶性疾病的2%-3%,并且倾向于浸润周围相邻结构,具有血管侵袭的生物学易感性。这种对静脉系统的趋向性使得高达25%的RCC患者肿瘤扩散至肾静脉和下腔静脉(IVC)。手术切除仍然是伴有静脉瘤栓(TT)延伸的RCC的主要治疗方法,也是实现潜在治愈的唯一希望。更高的瘤栓水平与更晚期的疾病阶段相关,因此生存率更低。尽管在这些肿瘤切除过程中已成功实施了伴有循环停止的体外循环(CPB),但其应用仍存在争议,因为存在凝血病、血小板功能障碍和中枢神经系统并发症的风险。通过运用肝脏游离操作,无需开胸和CPB即可实现完全切除腹腔内III级瘤栓。本综述的目的是提供关于这些伴有膈上肿瘤栓子的RCC疑难病例手术治疗的最新情况,包括对避免开胸和体外循环(CPB)的基于移植技术的描述,以尽量减少术中和术后并发症。